Common use of Subsequent Equity Sales Clause in Contracts

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 8 contracts

Samples: Securities Purchase Agreement (Creatd, Inc.), Securities Purchase Agreement (Motus GI Holdings, Inc.), Securities Purchase Agreement (Actelis Networks Inc)

AutoNDA by SimpleDocs

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Datehereafter, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementEquivalents.

Appears in 8 contracts

Samples: Underwriting Agreement (Dolphin Entertainment, Inc.), Underwriting Agreement (Dolphin Entertainment, Inc.), Underwriting Agreement (Airborne Wireless Network)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (Xtant Medical Holdings, Inc.), Securities Purchase Agreement (Rocketfuel Blockchain, Inc.), Securities Purchase Agreement (International Land Alliance Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (enVVeno Medical Corp), Securities Purchase Agreement (WeTrade Group Inc.), Securities Purchase Agreement (ASP Isotopes Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after following the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 7 contracts

Samples: Securities Purchase Agreement (Oncocyte Corp), Securities Purchase Agreement (Arcadia Biosciences, Inc.), Securities Purchase Agreement (NextPlat Corp)

Subsequent Equity Sales. (a) From Except with respect to the issuances described on Schedule 4.13 hereto, from the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 5 contracts

Samples: Securities Purchase Agreement (Ensysce Biosciences, Inc.), Securities Purchase Agreement (Isun, Inc.), Securities Purchase Agreement (Ensysce Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementEquivalents.

Appears in 5 contracts

Samples: Securities Purchase Agreement (Vycor Medical Inc), Securities Purchase Agreement (Fibrocell Science, Inc.), Securities Purchase Agreement (Vu1 CORP)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 4 contracts

Samples: Securities Purchase Agreement (Vivos Therapeutics, Inc.), Securities Purchase Agreement (Iveda Solutions, Inc.), Securities Purchase Agreement (Dermata Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty the date that is six (606) days after months following the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementEquivalents.

Appears in 4 contracts

Samples: Securities Purchase Agreement (Iconic Brands, Inc.), Securities Purchase Agreement (Iconic Brands, Inc.), Securities Purchase Agreement (Iconic Brands, Inc.)

Subsequent Equity Sales. (ai) From the date hereof until sixty (60) 180 days after following the Effective Datedate hereof, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement theretoOrdinary Share Equivalents. For the purposes hereof, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Underwriting Agreement (Therapix Biosciences Ltd.), Underwriting Agreement (Therapix Biosciences Ltd.), Underwriting Agreement (Therapix Biosciences Ltd.)

Subsequent Equity Sales. (a) From Except as provided in paragraph (c) below, from the date hereof until sixty (60) 120 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreementwhich a Person is entitled to acquire shares of Common Stock at an effective price per share that is less than $3.25.

Appears in 3 contracts

Samples: Securities Purchase Agreement (BioSig Technologies, Inc.), Securities Purchase Agreement (BioSig Technologies, Inc.), Securities Purchase Agreement (BioSig Technologies, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or without the prior written approval of the Preferred Director (ii) file any registration statement or any amendment or supplement thereto, as defined in each case other than as contemplated pursuant to the Registration Rights AgreementSection 4.18).

Appears in 3 contracts

Samples: Securities Purchase Agreement (MICT, Inc.), Securities Purchase Agreement (MICT, Inc.), Form of Securities Purchase Agreement (BNN Technology PLC)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Xtant Medical Holdings, Inc.), Securities Purchase Agreement (Biofrontera Inc.), Securities Purchase Agreement (Intec Parent Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days after the Effective DateDate (such applicable period, the “Restricted Period”), neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty twelve (6012) days after the Effective Datemonths, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementOrdinary Share Equivalents.

Appears in 3 contracts

Samples: Underwriting Agreement (Virax Biolabs Group LTD), Underwriting Agreement (Virax Biolabs Group LTD), Underwriting Agreement (Virax Biolabs Group LTD)

Subsequent Equity Sales. (ai) From the date hereof until the date that is sixty (60) days after following the Effective Datedate hereof, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementEquivalents.

Appears in 3 contracts

Samples: Underwriting Agreement (ImmunoCellular Therapeutics, Ltd.), Underwriting Agreement (Immune Pharmaceuticals Inc), Underwriting Agreement (Immune Pharmaceuticals Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 120 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (iiEquivalents; provided, however, if such issuance is in connection with an up-listing to a “national securities exchange” as defined in Rule 600(b) file of Regulation NMS, such issuance may occur at any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to time after the Registration Rights AgreementReverse Stock Split Date.

Appears in 3 contracts

Samples: Share Purchase Agreement (Edison Nation, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.), Securities Purchase Agreement (Delcath Systems, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days after following the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementAgreement or filing a registration statement on Form S-8 in connection with any employee compensation plan.

Appears in 3 contracts

Samples: Securities Purchase Agreement (T2 Biosystems, Inc.), Securities Purchase Agreement (Cyclacel Pharmaceuticals, Inc.), Securities Purchase Agreement (Lipella Pharmaceuticals Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after following the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Healthcare Triangle, Inc.), Securities Purchase Agreement (MMEX Resources Corp), Securities Purchase Agreement (Clearone Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (BigBear.ai Holdings, Inc.), Securities Purchase Agreement (Creative Medical Technology Holdings, Inc.), Securities Purchase Agreement (NewAge, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty one hundred eighty (60180) days after following the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or Equivalents, (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementProspectus or (iii) amend, modify or waiver the terms of any securities outstanding on the date hereof.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Ontrak, Inc.), Securities Purchase Agreement (Ontrak, Inc.), Securities Purchase Agreement (Ontrak, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementProspectus Supplement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Orbital Energy Group, Inc.), Securities Purchase Agreement (Orbital Energy Group, Inc.), Securities Purchase Agreement (Orbital Energy Group, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementOrdinary Share Equivalents.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Safe-T Group Ltd.), Securities Purchase Agreement (BioLineRx Ltd.), Securities Purchase Agreement (BioLineRx Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Citius Pharmaceuticals, Inc.), Securities Purchase Agreement (Phio Pharmaceuticals Corp.), Securities Purchase Agreement (Caladrius Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 45 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Movano Inc.), Securities Purchase Agreement (Biofrontera Inc.), Securities Purchase Agreement (Cancer Genetics, Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days after the Effective DateDate (the “Lock-Up Period”), neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement for Units (Tenax Therapeutics, Inc.), Securities Purchase Agreement for Units (Tenax Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Arcimoto Inc), Securities Purchase Agreement (Silo Pharma, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementOrdinary Share Equivalents.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Rosetta Genomics Ltd.), Securities Purchase Agreement (Rosetta Genomics Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days months after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to without the Registration Rights Agreementprior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Xenetic Biosciences, Inc.), Underwriting Agreement (Xenetic Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Actelis Networks Inc), Securities Purchase Agreement (Odyssey Health, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective DateClosing, neither the Company nor any Subsidiary subsidiary shall (i) issue, enter into any agreement to issue issue, or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Equivalents Ordinary Share Equivalents, or (ii) file or amend any registration statement or any amendment or supplement theretoprospectus, in each case other than as contemplated pursuant necessary to maintain the Registration Rights registration of the Securities governed by this Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (SuperCom LTD), Securities Purchase Agreement (SuperCom LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Innovative Payment Solutions, Inc.), Securities Purchase Agreement (Coretec Group Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Dateanniversary of the date of this Agreement, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Grom Social Enterprises, Inc.), Securities Purchase Agreement (Grom Social Enterprises, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) not issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreementwithout Majority Approval.

Appears in 2 contracts

Samples: Securities Purchase Agreement (VerifyMe, Inc.), Securities Purchase Agreement (VerifyMe, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents without the written approval of the Purchasers of 50.1% or (ii) file any registration statement or any amendment or supplement theretogreater of the Securities issued hereunder, in each case other than as contemplated pursuant to the Registration Rights Agreementbased on initial Subscription Amounts hereunder.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Inspyr Therapeutics, Inc.), Securities Purchase Agreement (Inspyr Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after 90 Trading Days following the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents. Notwithstanding the foregoing, this Section 4.19 shall not apply in respect of (x) an Exempt Issuance or (iiy) file any filing by the Company of a registration statement statement, prospectus or any amendment other document with the Commission or supplement thereto, in each case other than as contemplated related announcement pursuant to the Investors’ Rights Agreement or the Registration Rights Agreement.

Appears in 2 contracts

Samples: Underwriting Agreement (Ceres, Inc.), Underwriting Agreement (Ceres, Inc.)

Subsequent Equity Sales. (a) From the Closing Date until the date hereof until sixty that is thirty (6030) trading days after the Effective Datethereafter, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of (i) Common Stock Shares or Common Stock Share Equivalents or (ii) file convertible debt securities (and underlying shares upon the conversion thereof) to any registration statement of the officers (or any amendment their affiliated entities) or supplement theretodirectors of the Company, in each case other than as contemplated pursuant to without the Registration Rights Agreementprior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Cesca Therapeutics Inc.), Underwriting Agreement (Intellipharmaceutics International Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective 180th day following the IPO Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Smart for Life, Inc.), Securities Purchase Agreement (Bluejay Diagnostics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (BlackSky Technology Inc.), Securities Purchase Agreement (Brooklyn ImmunoTherapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 180 days after following the Effective Execution Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementOrdinary Share Equivalents.

Appears in 2 contracts

Samples: Underwriting Agreement (CardieX LTD), Underwriting Agreement (Cellect Biotechnology Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to without the Registration Rights Agreementprior written consent of the Representative.

Appears in 2 contracts

Samples: Underwriting Agreement (Castor Maritime Inc.), Underwriting Agreement (Castor Maritime Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementAgreement or to register for resale the shares underlying the Company’s outstanding warrants.

Appears in 2 contracts

Samples: Securities Purchase Agreement (SHF Holdings, Inc.), Securities Purchase Agreement (Northern Lights Acquisition Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Peraso Inc.), Securities Purchase Agreement (Peraso Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as (i) contemplated pursuant to the Registration Rights AgreementAgreement or (ii) necessary to maintain the effectiveness of existing registration statements which are effective as of the Effective Date.

Appears in 2 contracts

Samples: Securities Purchase Agreement (VerifyMe, Inc.), Securities Purchase Agreement (GeoVax Labs, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days after the Effective Datemonths, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any supplement or amendment or supplement thereto, in each case thereto (other than as contemplated pursuant to the Registration Rights Agreementin connection with this offering).

Appears in 2 contracts

Samples: Underwriting Agreement (Cyclo Therapeutics, Inc.), Cyclo Therapeutics, Inc.

Subsequent Equity Sales. (a) From Without the prior consent of the Placement Agents or the Purchasers representing a majority of the aggregate Subscription Amount in this offering, from the date hereof until sixty (60) 60 days after the Effective Datedate hereof, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents, except for any at-the-market offerings or (ii) file equity lines of credit or in connection with any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreementstrategic collaboration.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Better Therapeutics, Inc.), Securities Purchase Agreement (Better Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty one hundred twenty (60120) days after the Effective Termination Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file file, amend or supplement any registration statement or any amendment or supplement theretostatement, in each case other than as a registration statement contemplated pursuant to by the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (CIPHERLOC Corp)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than (a) as contemplated pursuant to the Registration Rights AgreementAgreement or (b) the filing of a registration statement, including any amendment or supplement thereto, on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Essetifin SPA)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement, and other than a prospectus supplement to be filed in connection with the Registered Direct.

Appears in 1 contract

Samples: Securities Purchase Agreement (Avinger Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents without the express prior written consent of a majority in interest of the Purchasers, not to be unreasonably withheld or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreementdelayed.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cortex Pharmaceuticals Inc/De/)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Form of Securities Purchase Agreement (ReWalk Robotics Ltd.)

Subsequent Equity Sales. (a) From Except with respect to the issuances described on Schedule 4.13 hereto, from the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (CENNTRO ELECTRIC GROUP LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementProspectus.

Appears in 1 contract

Samples: Securities Purchase Agreement (Harbor Custom Development, Inc.)

Subsequent Equity Sales. (a) From the date hereof until [sixty (60) days days] after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents or (ii) file any registration statement or any amendment or supplement theretoeach, in each case other than as contemplated pursuant to the Registration Rights Agreementa “Subsequent Placement”).

Appears in 1 contract

Samples: Form Securities Purchase Agreement (WiMi Hologram Cloud Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty one hundred twenty (60120) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement with the Commission related to the offering of any shares of Common Stock or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementCommon Stock equivalents.

Appears in 1 contract

Samples: Underwriting Agreement (Beam Global)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days after from the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Shares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant except that the Company may enter into a public or private offering of convertible debt involving a Variable Rate Transaction of up to $800,000 (the Registration Rights Agreement“Exempt Offering”).

Appears in 1 contract

Samples: Securities Purchase Agreement (Dunxin Financial Holdings LTD)

Subsequent Equity Sales. (a) From the date hereof until the date that is sixty (60) days after the Effective Dateeffective date of the Registration Statement, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementEquivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (NeuroMetrix, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days six months after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares, ADSs, or Common Stock Ordinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case thereto (other than as contemplated pursuant to the Registration Rights AgreementProspectus Supplement).

Appears in 1 contract

Samples: Securities Purchase Agreement (Molecular Data Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementAgreement or filing a registration statement on Form S-8 in connection with any employee benefit plan.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cadrenal Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents, including, without limitation, the filing of a registration statement or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (ZW Data Action Technologies Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock ADSs, Ordinary Shares or Common Stock Ordinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (TC BioPharm (Holdings) PLC)

AutoNDA by SimpleDocs

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents, other than a transaction for the sale of Company securities to one or more of the Purchasers that purchase a majority of the Preferred Stock sold pursuant to this Agreement or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Healthier Choices Management Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Creek Road Miners, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty-five (6035) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Share Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (ReWalk Robotics Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant the Prospectus Supplement or the filing of a registration statement or any amendment thereto with respect to the Registration Rights AgreementCommon Warrant Shares and the Private Placement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Inhibikase Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementOrdinary Shares Equivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Top Image Systems LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty one hundred twenty (60120) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement with the Commission related to the offering of any shares of Common Stock or any amendment or supplement thereto, in each case Common Stock equivalents other than as contemplated pursuant to the Registration Rights AgreementProspectus Supplement.

Appears in 1 contract

Samples: Underwriting Agreement (Contango ORE, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty forty-five (6045) days after the Effective Date, Closing Date neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents, without the prior approval of either not less than 50.1% of the holders in interest of the Shares based on the initial Subscription Amounts hereunder, or (ii) file any registration statement the Placement Agent, which approval shall not be unreasonably withheld or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreementdelayed.

Appears in 1 contract

Samples: Securities Purchase Agreement (authID Inc.)

Subsequent Equity Sales. (ai) From the date hereof until sixty (60) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights this Agreement.

Appears in 1 contract

Samples: Hepion Pharmaceuticals, Inc.

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Ordinary Shares or Common Stock Ordinary Shares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Diginex LTD)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementAgreement or a Form S-8 to register securities under the Company’s stock option plan.

Appears in 1 contract

Samples: Securities Purchase Agreement (UpHealth, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents. Notwithstanding the foregoing, this Section 4.12(a) shall not apply in respect of a bona fide firm commitment underwritten public offering of Common Stock or (ii) file any registration statement or any amendment or supplement theretoCommon Stock Equivalents, in each case other than as contemplated pursuant with gross cash proceeds to the Registration Rights AgreementCompany of $5,000,000 or more (a “Qualified Offering”).

Appears in 1 contract

Samples: Securities Purchase Agreement (GeoVax Labs, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 45 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement, other than a Registration Statement on Form S-4 in connection with the redomestication of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (SharpLink Gaming Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty one hundred and eighty (60180) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly, or announce the issuance foregoing or proposed issuance of any shares of Common Stock capital stock of the Company or Common Stock Equivalents Equivalents; or (ii) file or caused to be filed any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant with the Commission relating to the Registration Rights Agreementoffering of any shares of capital stock of the Company or Common Stock Equivalents.

Appears in 1 contract

Samples: Engagement Agreement (Telemynd, Inc.)

Subsequent Equity Sales. (a) From the date hereof until the later of (i) sixty (60) days after the Effective Date, and (ii) sixty (60) days after the “Shareholder Approval” (as defined in this Agreement) is obtained, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or equity of the Company or any Subsidiary, or (ii) file any registration statement or any amendment or supplement theretothereto on behalf of the Company or any Subsidiary, in each case other than as contemplated permitted pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Bridgeline Digital, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (ASP Isotopes Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty six (606) days months after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights by this Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Inhibikase Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective DateJune 12, 2009, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementEquivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Adventrx Pharmaceuticals Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents, or (ii) file incur any registration statement Indebtedness, without the express prior written consent of a majority in interest of the Purchasers, not to be unreasonably withheld or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreementdelayed.

Appears in 1 contract

Samples: Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementAgreement and other than any registration statement on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Molekule Group, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty twenty five (6025) calendar days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementAgreement (the "Lock-Up Period”).

Appears in 1 contract

Samples: Securities Purchase Agreement (Kalera Public LTD Co)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Scopus BioPharma Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant the Prospectus Supplement or the filing of a registration statement or any amendment thereto with respect to the Registration Rights AgreementPreferred Investment Option Shares and the Private Placement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Avinger Inc)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Smart for Life, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 180 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cleantech Acquisition Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Dateeffectiveness of the Registration Statement, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement. Notwithstanding the foregoing, this Section 4.10 shall not apply in respect of any Exempt Issuances.

Appears in 1 contract

Samples: Securities Purchase Agreement (Abeona Therapeutics Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty thirty (6030) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Staffing 360 Solutions, Inc.)

Subsequent Equity Sales. (a) From the date hereof Effective Date until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, except a registration statement on Form S-8. Notwithstanding the foregoing, this Section 4.17 shall not apply in each case other than as contemplated pursuant to the Registration Rights Agreementrespect of an Exempt Issuance.

Appears in 1 contract

Samples: Securities Purchase Agreement (LMP Automotive Holdings, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 45 days after the Effective Datedate on which the registration statement required to be filed by the Registration Rights Agreement is declared effective, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementEquivalents.

Appears in 1 contract

Samples: Securities Purchase Agreement (Lyra Therapeutics, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto. Notwithstanding the foregoing, this Section 4.12(a) may be waived in each case other than as contemplated pursuant to writing with the Registration Rights Agreementprior written consent of a majority in interest of the Purchasers hereunder (based on Subscription Amounts hereunder).

Appears in 1 contract

Samples: Securities Purchase Agreement (Crown Electrokinetics Corp.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 90 calendar days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementAgreement or any amendments to registration statements filed prior to the date of this Agreement so long as no new securities are registered on any such existing registration statements.

Appears in 1 contract

Samples: Securities Purchase Agreement (Intelligent Bio Solutions Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 60 trading days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights by this Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Alpine 4 Technologies Ltd.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) calendar days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents, or (ii) file any registration statement or any amendment or supplement thereto, in each case under the Securities Act other than as contemplated pursuant a resale registration statement relating to the Registration Rights AgreementWarrant Shares.

Appears in 1 contract

Samples: Securities Purchase Agreement (Datasea Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement, other than as otherwise permitted herein and the filing of any “shelf registration statement” on Form S-3.

Appears in 1 contract

Samples: Securities Purchase Agreement (Serve Robotics Inc. /DE/)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) 30 days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cellectar Biosciences, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after the Effective Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents Equivalents, or (ii) or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementProspectus Supplement.

Appears in 1 contract

Samples: Securities Purchase Agreement (American Resources Corp)

Subsequent Equity Sales. (ai) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights this Agreement.

Appears in 1 contract

Samples: Motus GI Holdings, Inc.

Subsequent Equity Sales. (a) From the date hereof until sixty (60) days after following the Effective DateDate pursuant to which all Shares and Warrant Shares are registered for resale, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Renovare Environmental, Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock Shares or Common Stock Shares Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement.

Appears in 1 contract

Samples: Securities Purchase Agreement (Very Good Food Co Inc.)

Subsequent Equity Sales. (a) From the date hereof until sixty ninety (6090) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights AgreementAgreement or a Registration Statement on Form S-8.

Appears in 1 contract

Samples: Securities Purchase Agreement (Salarius Pharmaceuticals, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!